Пентоксил

Quick links to important sections

Пентоксил

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Пентоксил

What is Pentoxyl?

Pentoxyl is a synthetic pharmacological agent classified as a pyrimidine derivative. It is primarily recognized for its role as a leukopoiesis stimulant and an immunomodulator. The compound is designed to support the body's internal regenerative processes and enhance the functional activity of the immune system.

Mechanism of Action

The primary action of Pentoxyl involves the stimulation of cell regeneration and the production of white blood cells (leukocytes) within the bone marrow. It belongs to a group of substances that influence nucleic acid metabolism, specifically accelerating the synthesis of pyrimidine bases. This metabolic acceleration supports the growth, differentiation, and proliferation of cells, which is particularly relevant in tissues requiring rapid repair or in the restoration of blood cell counts.

General Characteristics

Pentoxyl is characterized by several key biological properties:

  • Leukopoietic Stimulation: It helps increase the number of leukocytes in the blood, which is essential for maintaining a functional immune response.
  • Anabolic Activity: The agent exhibits mild anabolic properties, assisting in the synthesis of proteins and the repair of damaged tissues.
  • Immunomodulatory Effects: It promotes the production of antibodies and enhances the phagocytic activity of macrophages and neutrophils, the cells responsible for neutralizing foreign pathogens.
  • Anti-inflammatory Potential: By accelerating tissue repair and stabilizing metabolic processes, it can contribute to the reduction of localized inflammatory responses.

Therapeutic Context

Pentoxyl is typically utilized in clinical settings where the immune system is suppressed or where tissue healing is compromised. This includes conditions involving low white blood cell counts (leukopenia) or chronic inflammatory processes where the body's natural recovery mechanisms require additional support. Its development was rooted in the need for non-hormonal agents capable of influencing cellular recovery and systemic immunity.

What side effects are possible with Пентоксил?

Possible side effects and safety information

The official safety profile for the Pentoxifylline component of Пентоксил is structured by adverse reactions reported in regulatory documents, categorized by frequency and the body system affected. All safety information is based exclusively on formal regulatory labeling.


Documented Adverse Reactions and Frequencies

Adverse reactions are primarily associated with the gastrointestinal and nervous systems, and are often noted to be dose-related.

Classification Examples of Reactions Affected Systems (SOC)
Common Nausea, Vomiting, Dizziness, Headache Gastrointestinal, Nervous System
Less Common Angina, Hypotension, Tachycardia, Rash, Tremor Cardiac, Vascular, Skin
Rare Aplastic Anemia, Anaphylactic Reactions, Hepatitis Blood, Immune System, Hepatobiliary

Serious Safety Considerations

The regulatory labeling identifies risks of specific, clinically significant adverse effects. These include the potential for Intracranial or Retinal Hemorrhage, particularly when used concurrently with other medications that affect blood clotting. Severe Anaphylactic/Anaphylactoid reactions and Aplastic Anemia have also been documented as rare but serious adverse events.

Safety Restrictions and Special Populations

Use of the medication is Contraindicated in patients with recent cerebral or retinal hemorrhage, known hypersensitivity to pentoxifylline or other methylxanthines (e.g., theophylline), acute myocardial infarction, or peptic ulcers. Patients with renal impairment or hepatic impairment require close monitoring due to the potential for metabolite accumulation, and the drug is generally not recommended in cases of severe organ impairment.

Overdose and Emergency Response

The official regulatory documentation on overdose for Пентоксил (Pentoxifylline profile) strictly describes the potential clinical manifestations and the required emergency actions.

Documented Overdose Manifestations

Documented overdose presentations include specific Central Nervous System (CNS) effects such as drowsiness, agitation, fever, and unusual excitement, alongside gastrointestinal effects like nausea and vomiting. Additionally, vascular signs such as flushing have been reported.

Severe Systemic Events

The profile highlights the risk of severe systemic events, which include acute neurological complications like convulsions (seizures), and serious cardiovascular instability presenting as profound hypotension (low blood pressure) and loss of consciousness.

When to Seek Emergency Help

The regulatory guidance mandates that anyone with suspected overingestion must seek emergency medical attention immediately. Emergency services or a Poison Control Centre must be contacted without delay, particularly if severe manifestations like seizures or collapse are observed.

Official Management Statements

Management is officially directed toward symptomatic and supportive treatment. Procedures such as gastric lavage and administration of activated charcoal are described as appropriate initial steps. Treatment efforts focus on supporting respiration and maintaining systemic blood pressure. The regulatory documentation states that no specific antidote is known for this substance. Overdose events have been documented in both adults and children, with symptoms typically appearing 4 to 5 hours after ingestion and lasting approximately 12 hours.

Therapeutic Uses of Пентоксил

Пентоксил is generally utilized in situations involving certain distressing symptoms associated with compromised blood flow, where it is applied across domains where additional symptomatic support is needed. It provides supportive relief and is relevant to the overall management of conditions where functional stability becomes affected. The medication is commonly used to help manage symptoms related to conditions presenting with systemic or localized discomfort.

Key Symptomatic Domains

The medication is considered relevant to address symptoms that interfere with daily functioning, including those related to symptoms related to physical discomfort and chronic discomfort in the extremities. It is often used when symptoms intensify and supportive relief is needed, contributing to easing the overall symptom load associated with long-term issues. This supportive action is relevant for managing conditions involving episodic or fluctuating manifestations, as well as providing assistance in tissue repair complicated by poor circulation.


Quick Fact: Symptomatic Relief The medication is relevant for easing discomfort felt during activity, which supports general well-being during symptomatic phases.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Пентоксил (Pentoxifylline) — Official Regulatory Information


Eligibility Scope

Category Regulatory Status
Populations for whom use is allowed Adult patients who do not possess formal contraindications or high-risk conditions.
Populations for whom use is contraindicated Patients with recent cerebral or retinal hemorrhage; patients with recent acute myocardial infarction; patients with peptic ulcers or a recent history of ulceration; and individuals with known hypersensitivity to the drug or other methylxanthines (e.g., caffeine, theophylline).

Age- and Condition-Specific Eligibility

Category Regulatory Status / Restriction
Pediatric Patients (<18 years) Not recommended; safety and efficacy have not been established in this age group.
Geriatric Patients Use requires caution due to the greater frequency of decreased renal, hepatic, or cardiac function, often necessitating careful dose selection.
Severe Organ Impairment Not recommended in cases of severe renal impairment (creatinine clearance below 30 mL/min) or severe hepatic impairment due to increased drug exposure and risk.

Pregnancy and Lactation Eligibility

  • Pregnancy: Use is restricted (FDA Category C). The drug should only be used if the potential benefit justifies the potential risk to the fetus.
  • Lactation: Not recommended; the drug and its metabolites are excreted in human milk, requiring a decision to discontinue nursing or discontinue the medication.

Connection to the Overall Eligibility Profile

Official regulatory documents define non-eligibility by establishing formal contraindications for populations presenting with acute bleeding risks or hypersensitivity to the drug or related compounds. Furthermore, the documents impose restrictions on use for patients with severe organ impairment (hepatic/renal) and explicitly state that the drug’s safety is not established for pediatric populations. Standard use is permitted only for eligible adults who are free of these documented high-risk factors.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Pentoxifylline is primarily defined by the risk of bleeding and effects on drug concentrations, often necessitating dose adjustments or close monitoring.

Product Category Interacting Agents Practical Regulatory Implication
Anticoagulants (Vitamin K antagonists) Warfarin, Acenocoumarol Increased anticoagulant activity and bleeding risk are reported; requires more frequent monitoring of Prothrombin Time (INR).
Antiplatelet Agents Aspirin, Clopidogrel, Cilostazol Potential for additive effects that increase the risk of bleeding; requires monitoring for signs of hemorrhage.
NSAIDs Ketorolac, Aceclofenac The combination with Ketorolac is generally not recommended or contraindicated due to heightened bleeding risk.
Anti-hypertensive Agents Captopril, Nifedipine May lead to an enhanced hypotensive effect; requires periodic systemic blood pressure monitoring and potential dose reduction of the anti-hypertensive agent.
Xanthine Derivatives Theophylline Concomitant use can lead to increased Theophylline plasma levels and potential toxicity in some patients, requiring close monitoring and dose adjustment of Theophylline.
CYP1A2 Inhibitors Cimetidine, Ciprofloxacin, Fluvoxamine These agents increase the plasma concentration of Pentoxifylline and its active metabolites, which may increase the risk of adverse effects.
Guanylate Cyclase Stimulators Riociguat The co-administration of Pentoxifylline with Riociguat is explicitly documented as not recommended or contraindicated.

Mechanism of Action

Modulation of Blood Flow Dynamics and Hemorheology

This domain, associated with the Pentoxifylline profile, engages mechanisms involving phosphodiesterase (PDE) enzyme inhibition and subsequent cAMP signaling within vascular and blood cells. By blocking the breakdown of cAMP, the drug acts to increase the flexibility of red blood cells and promote the relaxation of peripheral blood vessel walls. This mechanistic sequence results in increased microcirculatory flow and reduced overall blood viscosity.

️ Regulation of Cytokine Signaling

Also characteristic of the Pentoxifylline profile, this mechanism operates within the inflammatory cascade by suppressing the gene transcription of pro-inflammatory mediators, such as Tumour Necrosis Factor-alpha (TNF-alpha). This modulation alters the magnitude of inflammatory signaling and reduces the adhesion of leukocytes to the vascular lining, which contributes to the modulation of targeted immune pathways.

Stimulation of Cellular Regeneration and Leukopoiesis

The Pentoxyl profile engages mechanisms that stimulate fundamental metabolic processes necessary for nucleic acid and protein synthesis. This activity promotes the differentiation and proliferation of cells in high-turnover tissues, most notably hematopoietic precursor cells. This mechanism contributes to the increase in cellular proliferation and accelerates the production of immune cells, resulting in physiological changes within the cellular defense system.

Dosage and Administration Information

How to Use Пентоксил — Administration Guidelines

Пентоксил is an oral medication that must be administered according to specific established rules.

Administration Requirements

Guideline Instruction
Route of Administration For oral use only (taken by mouth).
Timing in Relation to Meals Must be taken with meals or immediately after food to help minimize potential gastric irritation.
Dosing Frequency The usual adult regimen is typically 400 mg taken two or three times daily.

Procedural and Dose Adjustment Rules

Administration Method: Tablets (often extended-release) must be swallowed whole. They should not be crushed, broken, or chewed, as this can affect the controlled release of the medicine and alter absorption.

Missed Dose: If a dose is missed, take it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular schedule resumed. Doses must never be doubled.

Dose Adjustment: The dose may be reduced in patients with impaired kidney or liver function due to the potential for the drug or its active metabolites to accumulate. For example, the dose may be reduced from three times daily to twice daily (800 mg/day) if gastrointestinal or central nervous system side effects occur.

Duration of Use: The therapeutic effects may take time to develop; treatment is typically recommended for a minimum of eight weeks to determine efficacy.

Recent Clinical Evidence

Research Evidence / Overview of studies for Пентоксил

The official clinical trial research available for Пентоксил is specific to the compound's profile as a Hemorheologic Agent (Pentoxifylline), which is evaluated in research contexts involving fluctuating or unstable symptoms related to blood flow. The studies summarized here describe group patterns and contribute to the broader evidence landscape, but research does not determine whether an individual will respond similarly.


Evidence for Intermittent Claudication (IC) due to Poor Circulation

This section summarizes the structure of Randomized Controlled Trials (RCTs) and meta-analyses that have examined how the medication was measured against a placebo for effects on walking capacity and functional measures in adult patients with claudication.

The research primarily involves RCTs, with their findings summarized in broader systematic reviews. The studies explored functional assessments of walking ability, specifically measuring the distance patients could walk pain-free. When research explored short-term symptom changes, findings were mixed. Studies reported measurements of walking distance, which data show patterns related to only minimal variation when compared to a placebo. Objective physical measurements, such as the Ankle-Brachial Pressure Index (ABI), were observed in some studies to not demonstrate clear differences between groups.

The evidence available is generally described as being of low to moderate certainty. Long-term effects are not fully established for this indication.


Evidence for Chronic Venous Leg Ulcers (VLU)

This part details the findings from Randomized Controlled Trials (RCTs) that studied the use of the medication alongside standard care, such as compression therapy, focusing on the research assessing complete ulcer healing rates.

The primary research involves RCTs where the medication was evaluated in patients with chronic venous leg ulcers alongside compression bandages. Analysis of the combined data from these RCTs describes findings related to complete ulcer healing that were observed more frequently in the combination groups. This evidence level is Moderate; studies monitored its use alongside standard compression techniques.

A key research limitation is that there is limited information for long-term outcomes following successful healing, particularly regarding the rate of recurrence for venous ulcers.

Frequently Asked Questions (FAQ)

Common questions about Пентоксил (FAQ)


Q: Can I drink coffee or tea while taking Pentoxil?

A: Pentoxil (Pentoxifylline) is chemically classified as a derivative of methylxanthine compounds, which includes caffeine found in coffee and tea, and theophylline. Official regulatory instructions list hypersensitivity to methylxanthines as a contraindication. Official guidelines suggest consultation with a healthcare provider regarding the use of other methylxanthine-containing substances.


Q: Is there a risk of interaction between Pentoxil and alcohol?

A: According to official patient safety information, a specific chemical interaction between Pentoxil and alcohol is not formally established. However, official documentation suggests a potential for increased risk of dizziness or lightheadedness, which are known side effects of the medication.


Q: Does Pentoxil affect the ability to drive or operate machinery?

A: Official patient information indicates that Pentoxil may cause side effects like dizziness or lightheadedness. Because of these potential effects on the nervous system, regulatory safety information advises caution and suggests avoiding driving or operating heavy machinery until you are familiar with how the medication affects your body.


Q: What is the mechanism of action of Pentoxil in simple terms?

A: The drug is understood to influence the flow properties of blood, often described as increasing red blood cell flexibility and decreasing overall blood viscosity. This effect is intended to improve microcirculation, helping blood reach peripheral tissues.


Q: Can Pentoxil affect blood test results?

A: The medication may affect certain blood parameters. Due to its known action on blood viscosity and potential effects on clotting, regulatory documents require frequent monitoring of coagulation parameters, such as Prothrombin Time (INR), when used alongside anticoagulants. The medication’s profile also includes rare adverse events, such as Aplastic Anemia, which is related to blood cell production.


Q: Is a doctor's prescription needed to buy Pentoxil?

A: Yes. Regulatory classifications across many regions list products containing Pentoxifylline as Prescription Only (Rx). This classification indicates that the medication is dispensed under the professional control of a prescriber and is not available over-the-counter.


Q: Is Pentoxil generally considered safe, according to regulatory data?

A: Official regulatory documents describe Pentoxil (Pentoxifylline) as generally well-tolerated when used for its approved indications. However, the regulatory documents also list specific contraindications and potential serious adverse reactions. The medication is only regulated for use by patients free of these documented high-risk factors.


Q: How long does the active substance of Pentoxil stay in the body?

A: Pharmacokinetic data in official labeling indicates that the parent active substance, Pentoxifylline, has a very short plasma half-life, typically less than one hour. However, the active metabolites remain in the plasma for a longer duration, which contributes to the prolonged pharmacological activity of the drug.


Q: What should I do if a side effect is not mentioned in the official instructions?

A: Regulatory agencies encourage patients and healthcare professionals to report any suspected adverse reactions that are not listed in the official prescribing information. Regulatory safety programs, such as MedWatch, offer established mechanisms for submitting this information to authorities for safety monitoring.


Q: Can I stop taking Pentoxil suddenly if I feel better?

A: Official guidance advises against suddenly discontinuing the medication, even if an improvement in symptoms is noticed. It suggests consulting with a healthcare provider before making any changes to the prescribed course of treatment.


Q: How long do I need to stop taking Pentoxil before scheduled surgery?

A: Official warnings highlight the bleeding risk associated with the medication. A physician is likely to provide specific guidance regarding the temporary discontinuation of the medication prior to any planned surgical procedure, particularly those with a high risk of hemorrhage.


Q: Do I need to follow a special diet while taking Pentoxil?

A: Official drug interaction summaries do not specify the need for a special restrictive diet while taking this medication. The only common instruction regarding food consumption is that the tablets are typically taken with meals, which may help minimize the potential for gastric irritation.


Q: What are the signs of a Pentoxil overdose?

A: Regulatory resources list signs of a potential overdose, which may include symptoms such as drowsiness, flushing, faintness, or unusual agitation. More serious signs can involve seizures, a drop in blood pressure, and a rapid heartbeat.


Q: Does Pentoxil affect mood or sleep?

A: Yes, official adverse reaction lists indicate that Pentoxil may affect the central nervous system. Documented side effects that relate to sleep and mood include nervousness and insomnia (difficulty sleeping).


Q: How often should I undergo testing or monitoring while taking Pentoxil?

A: Regulatory guidance indicates that certain conditions require close monitoring. This may involve frequent testing of specific parameters, such as blood pressure or coagulation levels, especially when the drug is used with other interacting medicines or in patients with pre-existing organ impairment.


Q: What is the difference between Pentoxil injections and tablets?

A: The Pentoxifylline compound is available as extended-release oral tablets and as a sterile liquid solution for injection. The injection form is typically reserved for parenteral administration, which is a different route of delivery used in specific clinical contexts, unlike the oral tablets.

How should Пентоксил be stored and disposed of?

Storage and Disposal Information

Official regulatory guidance outlines specific requirements for storing, handling, and disposing of this medication to ensure its stability and prevent accidental exposure.

Storage Conditions

Requirement Official Instruction
Temperature Store at room temperature (e.g., 20°C to 25°C) and away from excess heat.
Protection Keep the medicine container tightly closed and protect it from moisture (do not store in a bathroom).
Safety Store all medication out of the sight and reach of children and pets, securing child-resistant caps immediately after use.

Disposal Rules

Requirement Official Instruction
General Disposal Unused or expired medication should not be flushed down a toilet or poured down a drain unless officially authorized.
Recommended Method Dispose of the product following local government guidelines, often by utilizing community drug take-back programs or designated collection sites.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Пентоксил found in:

A-Z Index: